Access cutting-edge glioblastoma treatment through this clinical trial at a research site in Fayetteville. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Fayetteville location
Access glioblastoma specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related glioblastoma treatment provided free
Check if you qualify for this glioblastoma clinical trial in Fayetteville, AR
No-Cost Study Care
Local to Fayetteville
Convenient for AR residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomusti
Sponsor: NRG Oncology
Yes, this clinical trial (NCT05095376) has an active research site in Fayetteville, AR that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for glioblastoma treatment options in Fayetteville, AR, this clinical trial (NCT05095376) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fayetteville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced glioblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all glioblastoma clinical trials near you to find additional studies recruiting in your area.
See all brain cancer clinical trials recruiting in Fayetteville — not just this study.
Browse Brain Cancer Trials in Fayetteville →